Patent details

EP2931748 Title: BMP-6 ANTIBODIES

Basic Information

Publication number:
EP2931748
PCT Application Number:
PCT/US/2013/073239
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP138180450
PCT Publication Number:
WO/2014/099391
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BMP-6 ANTIBODIES
French Title of Invention:
ANTICORPS ANTI-BMP-6
German Title of Invention:
BMP-6-ANTIKÖRPER
SPC Number:

Dates

Filing date:
05/12/2013
Grant date:
05/10/2016
EP Publication Date:
05/10/2016
PCT Publication Date:
26/06/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/10/2015
EP B1 Publication Date:
05/10/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/12/2018
Expiration date:
05/12/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/12/2013
 
 

Name:
Eli Lilly and Company
Address:
Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
30/11/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
TRUHLAR Stephanie Marie Eaton
Address:
United States (US)

2

Name:
SEO Neungseon
Address:
United States (US)

Priority

Priority Number:
201261737859
Priority Date:
17/12/2012
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/22;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
05/12/2017
Last Annual Fee Paid Number:
5
Last Annual Fee Paid Amount:
52 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages
30/04/2019 Outgoing Correspondence 1